Prophylactic immunoglobulin therapy for pediatric congenital myotonic dystrophy

Prophylactic immunoglobulin therapy for pediatric congenital myotonic dystrophy

AbstractCongenital Myotonic Dystrophy (CMD) is an autosomal dominant hereditary disease caused by mutations in the dystrophia myotonica protein kinase gene. Patients with CMD often exhibit low immunoglobulin (Ig) G levels. While Ig replacement therapy for low IgG levels has been reported in several...

Full description

Bibliographic Details
Main Authors: Yoji Uejima, Satoshi Sato
Format: Article
Language:English
Published: Taylor & Francis Group 2024-04-01
Series:Immunological Medicine
Subjects:
Hypogammaglobulinemia
pediatric congenital myotonic dystrophy
intravenous immunoglobulins
subcutaneous immunoglobulins
neonatal fc receptor
Online Access:https://www.tandfonline.com/doi/10.1080/25785826.2024.2306672

Internet

https://www.tandfonline.com/doi/10.1080/25785826.2024.2306672

Similar Items